IndraLab

Statements


TBMS-1 decreases the amount of STAMBPL1. 5 / 5
| 5

reach
"However, TBMS-1 significantly downregulated the expression of STAMBPL1, a DUB of c-FLIP, but had no effect on other DUBs (USP2, USP8, and USP9x) (Figure 4A)."

reach
"Additionally, TBMS-1 treatment downregulated c-FLIP and STAMBPL1 expression in HeLa and A549 cells; however, such effects were absent in normal EA.hy926 cells (Figure 4B)."

reach
"Interestingly, the results of this study showed that TBMS-1 only downregulates STAMBPL1 expression (Figure 4A,B)."

reach
"These findings were further confirmed in vivo using a xenograft model based on the observation that combined treatment with TBMS-1 and TRAIL decreased tumor volume and downregulated STAMBPL1 and c-FLIP expression levels."

reach
"Importantly, the combination of TBMS-1 and TRAIL therapy reduced the tumor volume and downregulated the expression levels of STAMBPL1 and c-FLIP in an in vivo xenograft model."